A 28-year-old woman presents with a 3-week history of sudden-onset, rapidly progressive facial eruption. She describes abrupt disfigurement with confluent erythematous-violaceous plaques studded with pustules, cysts, and coalescent nodules on her forehead, cheeks, nose, and chin. The structure marked **A** in the diagram shows these confluent inflammatory nodules on the central face. Notably, she has no comedones, her trunk is unaffected, and she reports recent emotional stress and is on oral contraceptives. Systemic features are absent. What is the most appropriate initial management strategy for this condition?
A. Oral minocycline alone with intralesional triamcinolone for individual lesions
B. Topical retinoids and oral antihistamines with observation for spontaneous resolution
C. Topical benzoyl peroxide and oral doxycycline monotherapy for 8–12 weeks
D. Oral isotretinoin (0.2–0.5 mg/kg/day) combined with systemic corticosteroids (prednisolone 0.5–1 mg/kg/day) with strict contraception
Explanation
Why oral isotretinoin combined with systemic corticosteroids is correct
Rosacea fulminans (formerly pyoderma faciale) is a rare, severe, explosive inflammatory eruption characterized by the abrupt onset of confluent erythematous-violaceous plaques with pustules, cysts, and coalescent nodules on the central face—exactly as depicted in structure A. The absence of comedones, trunk sparing, and young female demographic (peak 20s–30s) are diagnostic hallmarks. According to Bolognia Dermatology 5e, the standard of care for this condition requires prompt, aggressive systemic therapy to minimize scarring. First-line treatment is oral isotretinoin (started conservatively at 0.2–0.5 mg/kg/day to avoid initial flare, then gradually escalated) combined with systemic corticosteroids (prednisolone 0.5–1 mg/kg/day for 2–4 weeks, then tapered). Strict contraception is mandatory due to isotretinoin's teratogenicity. This combination addresses both the acute inflammatory burden and prevents the permanent atrophic and hypertrophic scarring that can result from delayed or inadequate treatment.
Why each distractor is wrong
Topical benzoyl peroxide and oral doxycycline monotherapy: While tetracyclines (doxycycline, minocycline) may be used as alternatives or adjuncts in milder cases or where isotretinoin is contraindicated, monotherapy with these agents is insufficient for the severe, fulminant presentation shown in A. Topical benzoyl peroxide alone is inadequate for this degree of inflammation and coalescent nodule formation.
Oral minocycline alone with intralesional triamcinolone: Minocycline monotherapy lacks the potency needed for rosacea fulminans. Intralesional triamcinolone is a useful adjunct for individual cysts to reduce scarring, but it cannot replace systemic isotretinoin and corticosteroids in a fulminant case.
Topical retinoids and oral antihistamines with observation: This approach is far too conservative for the severe, rapidly progressive eruption depicted in A. Observation without aggressive systemic therapy risks permanent disfiguring scarring and is psychologically harmful to the patient. Topical retinoids are not first-line for rosacea fulminans.
